News Daily News Shifting Acute MI Outcomes by Medicare Type: A Window Into Insurer’s Influence L.A. McKeown December 09, 2022
News Daily News Nuisance Bleeds on DAPT Not Just an Annoyance: TALOS-AMI Analysis Caitlin E. Cox November 30, 2022
News Daily News P2Y12 Inhibitors Top Aspirin Following Post-PCI DAPT: Network Meta-analysis Todd Neale November 21, 2022
News Daily News Single-Center Study Offers Insights for Ticagrelor vs Prasugrel in Chronic CAD Yael L. Maxwell November 21, 2022
News Daily News Many STEMI Patients Not Treated Within National Time Goals Michael O'Riordan November 15, 2022
News Conference News AHA 2022 Cangrelor After Ticagrelor Pretreatment in ACS Might Be OK: SWAP-5 Yael L. Maxwell November 11, 2022
News Conference News AHA 2022 Chinese Medicine Tongxinluo Yields ‘Surprising’ Benefits Post-STEMI: CTS-AMI Shelley Wood November 10, 2022
News Conference News AHA 2022 RESPECT-EPA: Missed Primary Endpoint but Hints of Benefit With Icosapent Ethyl Todd Neale November 10, 2022
News Conference News AHA 2022 Another OPTION? Indobufen Noninferior to Aspirin Following Successful PCI Yael L. Maxwell November 10, 2022
Presentation AHA 2022 Bivalirudin Plus a High-dose Infusion Versus Heparin Monotherapy in Patients with STEMI Undergoing Primary PCI: The BRIGHT-4 Trial Presenter: Gregg W. Stone November 07, 2022
News Conference News AHA 2022 BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI Shelley Wood November 06, 2022
News Daily News Renal Function Affects Ticagrelor/Aspirin Impact on Recurrent Stroke: CHANCE-2 Yael L. Maxwell November 03, 2022
News Daily News New Biomarker-Based Risk Score Performs Well in ACS Michael O'Riordan October 25, 2022
News Conference News EACTS 2022 FFR/iFR No Help in CABG Surgery in SWEDEHEART Registry Michael O'Riordan October 07, 2022
News Conference News TCT 2022 PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI Shelley Wood September 22, 2022
News Conference News TCT 2022 SCAAR Registry Delves Into Left Main Revascularization Outcomes Michael O'Riordan September 19, 2022
News Daily News COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK Michael O'Riordan September 15, 2022
News Industry News TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism September 13, 2022
News Conference News ESC 2022 CV Care Around Noncardiac Surgery: New ESC Guidelines Michael O'Riordan September 07, 2022